N, R., D, G., H, S., J, B., & J, A. (2026). De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making. American journal of cardiovascular drugs : drugs, devices, and other interventions. https://doi.org/10.1007/s40256-026-00806-8
Chicago Style (17th ed.) CitationN, Radfar, Gala D, Singh H, Bello J, and Allencherril J. "De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making." American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions 2026. https://doi.org/10.1007/s40256-026-00806-8.
MLA (9th ed.) CitationN, Radfar, et al. "De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making." American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions, 2026, https://doi.org/10.1007/s40256-026-00806-8.